Literature DB >> 14988676

Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

Esther A Coors1, Peter von den Driesch.   

Abstract

Photodynamic therapy after topical application of 5-aminolevulinic acid is an effective therapy for nonmelanoma epithelial skin cancers. It has also been used for some cases of cutaneous T-cell lymphoma. We treated 4 patients with different cutaneous T-cell lymphomas with photodynamic therapy. Those patients had previously reached a partial remission with more conventional therapies, but single lesions had remained. In all of these cases a complete remission of these lesions was achieved. We, therefore, suggest that photodynamic therapy can be a useful additional treatment modality for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988676     DOI: 10.1016/s0190-9622(03)00868-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

Review 2.  Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Authors:  M Lam; A H Hsia; Y Liu; M Guo; A R Swick; J C Berlin; T S McCormick; M E Kenney; N L Oleinick; K D Cooper; E D Baron
Journal:  Clin Exp Dermatol       Date:  2011-05-30       Impact factor: 3.470

Review 3.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

Review 4.  Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard.

Authors:  Brian Poligone; Peter Heald
Journal:  Dermatol Clin       Date:  2010-07       Impact factor: 3.478

5.  Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma.

Authors:  Katrin Agnes Salva; Gary S Wood
Journal:  Photochem Photobiol       Date:  2015-10-12       Impact factor: 3.421

6.  Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.

Authors:  Alex Y Huang; Jay T Myers; Deborah Barkauskas; Scott J Howell; Nancy L Oleinick; Thomas S McCormick; Kevin D Cooper; Elma D Baron; Minh Lam
Journal:  Photodiagnosis Photodyn Ther       Date:  2012-02-23       Impact factor: 3.631

7.  Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Authors:  Janet Y Li; Steven Horwitz; Alison Moskowitz; Patricia L Myskowski; Melissa Pulitzer; Christiane Querfeld
Journal:  Cancer Manag Res       Date:  2012-03-12       Impact factor: 3.989

8.  Emerging treatment options for early mycosis fungoides.

Authors:  Montserrat Fernandez-Guarino
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-02-18

Review 9.  Current evidence and applications of photodynamic therapy in dermatology.

Authors:  Marilyn T Wan; Jennifer Y Lin
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.